{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,1,16]],"date-time":"2026-01-16T10:54:57Z","timestamp":1768560897371,"version":"3.49.0"},"reference-count":10,"publisher":"Elsevier BV","issue":"1","license":[{"start":{"date-parts":[[2020,1,1]],"date-time":"2020-01-01T00:00:00Z","timestamp":1577836800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2020,1,1]],"date-time":"2020-01-01T00:00:00Z","timestamp":1577836800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2019,10,29]],"date-time":"2019-10-29T00:00:00Z","timestamp":1572307200000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"content-domain":{"domain":["jaadcasereports.org","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["JAAD Case Reports"],"published-print":{"date-parts":[[2020,1]]},"DOI":"10.1016\/j.jdcr.2019.10.022","type":"journal-article","created":{"date-parts":[[2019,12,24]],"date-time":"2019-12-24T05:54:03Z","timestamp":1577166843000},"page":"19-22","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":6,"title":["Immunosuppression-associated primary cutaneous plasmablastic lymphoma secondary to romidepsin"],"prefix":"10.1016","volume":"6","author":[{"given":"Collin M.","family":"Costello","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Connor J.","family":"Maly","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Sam","family":"Snider","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Kevin J.","family":"Severson","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"David J.","family":"DiCaudo","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Allison C.","family":"Rosenthal","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Donald W.","family":"Northfelt","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"William","family":"Rule","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Fiona E.","family":"Craig","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Mark R.","family":"Pittelkow","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Aaron R.","family":"Mangold","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"issue":"15","key":"10.1016\/j.jdcr.2019.10.022_bib1","doi-asserted-by":"crossref","first-page":"2323","DOI":"10.1182\/blood-2014-10-567479","article-title":"The biology and treatment of plasmablastic lymphoma","volume":"125","author":"Castillo","year":"2015","journal-title":"Blood"},{"issue":"5","key":"10.1016\/j.jdcr.2019.10.022_bib2","doi-asserted-by":"crossref","first-page":"794","DOI":"10.1016\/j.jaad.2006.06.043","article-title":"Presence of p16 hypermethylation and Epstein-Barr virus infection in transplant-associated hematolymphoid neoplasm of the skin","volume":"55","author":"Arbiser","year":"2006","journal-title":"J Am Acad Dermatol"},{"issue":"6","key":"10.1016\/j.jdcr.2019.10.022_bib3","doi-asserted-by":"crossref","first-page":"e315","DOI":"10.1016\/j.jaad.2013.07.003","article-title":"Cutaneous plasmablastic lymphoma in a nonimmunocompromised patient","volume":"69","author":"Eke","year":"2013","journal-title":"J Am Acad Dermatol"},{"issue":"3","key":"10.1016\/j.jdcr.2019.10.022_bib4","doi-asserted-by":"crossref","first-page":"287","DOI":"10.1159\/000077324","article-title":"Cutaneous plasmablastic lymphoma in an HIV-positive male: an unrecognized cutaneous manifestation","volume":"208","author":"Hausermann","year":"2004","journal-title":"Dermatology"},{"issue":"5","key":"10.1016\/j.jdcr.2019.10.022_bib5","doi-asserted-by":"crossref","first-page":"e202","DOI":"10.1016\/j.jaad.2012.02.021","article-title":"Primary cutaneous plasmablastic lymphoma of the lower leg in an HIV-negative patient","volume":"67","author":"Heiser","year":"2012","journal-title":"J Am Acad Dermatol"},{"issue":"5","key":"10.1016\/j.jdcr.2019.10.022_bib6","doi-asserted-by":"crossref","DOI":"10.5070\/D3225030944","article-title":"Plasmablastic lymphoma: an atypical cutaneous presentation of a rare entity","volume":"22","author":"Mota","year":"2016","journal-title":"Dermatol Online J"},{"key":"10.1016\/j.jdcr.2019.10.022_bib7","first-page":"541783","article-title":"Cutaneous plasmablastic lymphoma in an immunocompetent patient with long-term pyrimethamine use for essential thrombocythemia: a case report and literature review","volume":"2013","author":"Tiong","year":"2013","journal-title":"Case Rep Hematol"},{"issue":"7","key":"10.1016\/j.jdcr.2019.10.022_bib8","doi-asserted-by":"crossref","first-page":"1753","DOI":"10.1080\/10428194.2017.1393666","article-title":"Primary cutaneous plasmablastic lymphoma in an immunocompetent patient: is it associated with an indolent course?","volume":"59","author":"Beltran","year":"2018","journal-title":"Leuk Lymphoma"},{"issue":"1","key":"10.1016\/j.jdcr.2019.10.022_bib9","doi-asserted-by":"crossref","first-page":"83","DOI":"10.4103\/0378-6323.192953","article-title":"Primary cutaneous plasmablastic lymphoma presenting as perineal ulcero-proliferative growth in a human immunodeficiency virus-seropositive patient","volume":"83","author":"Behera","year":"2017","journal-title":"Indian J Dermatol Venereol Leprol"},{"issue":"3","key":"10.1016\/j.jdcr.2019.10.022_bib10","doi-asserted-by":"crossref","first-page":"377","DOI":"10.1158\/1055-9965.EPI-06-1069","article-title":"Non-Hodgkin lymphoma secondary to cancer chemotherapy","volume":"16","author":"Krishnan","year":"2007","journal-title":"Cancer Epidemiol Biomarkers Prev"}],"container-title":["JAAD Case Reports"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2352512619306733?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2352512619306733?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,11,7]],"date-time":"2025-11-07T00:20:52Z","timestamp":1762474852000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S2352512619306733"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2020,1]]},"references-count":10,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2020,1]]}},"alternative-id":["S2352512619306733"],"URL":"https:\/\/doi.org\/10.1016\/j.jdcr.2019.10.022","relation":{},"ISSN":["2352-5126"],"issn-type":[{"value":"2352-5126","type":"print"}],"subject":[],"published":{"date-parts":[[2020,1]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Immunosuppression-associated primary cutaneous plasmablastic lymphoma secondary to romidepsin","name":"articletitle","label":"Article Title"},{"value":"JAAD Case Reports","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.jdcr.2019.10.022","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2019 by the American Academy of Dermatology, Inc. Published by Elsevier, Inc.","name":"copyright","label":"Copyright"}]}}